Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Tadayuki Ishiyama is active.

Publication


Featured researches published by Tadayuki Ishiyama.


Tetrahedron Letters | 1996

Structure of angelmicin B, A novel src signal transduction inhibitor

Hiroshi Hori; Kazuaki Higashi; Tadayuki Ishiyama; Masakazu Uramoto; Yoshimasa Uehara; Toshikazu Oki

The structure of angelmicin B, which has been found to be a specific inhibitor of tyrosine kinase and src-dependent cell transformation, was determined. Angelmicin B consists of six deoxyhexoses and eight fused six-membered rings containing highly oxidized naphthylnaphthoquinone as a chromophore.


Bioscience, Biotechnology, and Biochemistry | 1996

Cutinostatin B as a New Cutinase Inhibitor Produced by Actinomycete.

Kazuaki Higashi; Jun Hirose; Hiroshi Hori; Tadayuki Ishiyama

Cutinostatin B was purified from a culture filtrate of a strain No. 3112-4 of an actinomycete which had been isolated from a soil sample collected in Setagaya-ku, Tokyo, Japan. The structure of this compound was determined mainly by 2D NMR experiments to be N(α)-[N(α)-(2,3-dihydroxybenzoyl)-ornithyl]-N(δ)-hydroxyornithine-δ-lactum. Cutinostatin B inhibited the cutinase activity of Cladosporium fulvum when using β-naphthyl caproate as the substrate with an IC50 value of 28.9 μm (11.0 μg/ml), and inhibited 95% when using crude apple cutin as the substrate with a concentration of 263 μM (100 μg/ml).


The Journal of Antibiotics | 1998

Signal transduction inhibitors, hibarimicins, A, B, C, D and G produced by Microbispora. I. Taxonomy, fermentation, isolation and physico-chemical and biological properties.

Takayuki Kajiura; Tamotsu Furumai; Yasuhiro Igarashi; Hiroshi Hori; Kazuaki Higashi; Tadayuki Ishiyama; Masakazu Uramoto; Yoshimasa Uehara; Toshikazu Oki


The Journal of Antibiotics | 2002

Biosynthesis of Hibarimicins

Yasuhiro Igarashi; Takayuki Kajiura; Tamotsu Furumai; Hiroshi Hori; Kazuaki Higashi; Tadayuki Ishiyama; Masakazu Uramoto; Yoshimasa Uehara; Toshikazu Oki


The Journal of Antibiotics | 2002

Biosynthesis of Hibarimicins : II. Elucidation of Biosynthetic Pathway by Cosynthesis Using Blocked Mutants

Takayuki Kajiura; Tamotsu Furumai; Yasuhiro Igarashi; Hiroshi Hori; Kazuaki Higashi; Tadayuki Ishiyama; Masakazu Uramoto; Yoshimasa Uehara; Toshikazu Oki


The Journal of Antibiotics | 1975

L-threo-beta-hydroxyaspartic acid as an antibiotic amino acid.

Tadayuki Ishiyama; Takaki Furuta; Makoto Takai; Yoichiro Okimoto


The Journal of Antibiotics | 2002

Biosynthesis of hibarimicins. I. 13C-labeling experiments.

Hiroshi Hori; Takayuki Kajiura; Yasuhiro Igarashi; Tamotsu Furumai; Kazuaki Higashi; Tadayuki Ishiyama; Masakazu Uramoto; Yoshimasa Uehara; Toshikazu Oki


The Journal of Antibiotics | 1998

Signal transduction inhibitors, hibarimicins A, B, C, D and G produced by Microbispora. II. Structural studies

Hiroshi Hori; Yasuhiro Igarashi; Takayuki Kajiura; Tamotsu Furumai; Kazuaki Higashi; Tadayuki Ishiyama; Masakazu Uramoto; Yoshimasa Uehara; Toshikazu Oki


The Journal of Antibiotics | 2000

Novel triene-β-lactone antibiotics, oxazolomycin derivative and its isomer, produced by Streptomyces sp. KSM-2690

Toshio Otani; Ken-Ichiro Yoshida; Hiromi Kubota; Shuji Kawai; Susumu Ito; Hiroshi Hori; Tadayuki Ishiyama; Toshikazu Oki


The Journal of Antibiotics | 1976

Deisovalerylblastmycin produced by Streptomyces SP.

Tadayuki Ishiyama; Toyoshige Endo; Noboru Otake; Hiroshi Yonehara

Collaboration


Dive into the Tadayuki Ishiyama's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Tamotsu Furumai

Toyama Prefectural University

View shared research outputs
Top Co-Authors

Avatar

Yasuhiro Igarashi

Toyama Prefectural University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Akira Kawashima

Taisho Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge